| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.06 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.06 |